In tumor immune microenvironment research, the roles of MUC1 and MUC16 in regulating mechanisms by which tumor cells evade immune surveillance, and how these proteins influence immune escape and treatment response through different pathways, are currently focal points of investigation. This evidence concerns the gene MUC16 and neoplasm.